Home Cart Sign in  
Chemical Structure| 850649-61-5 Chemical Structure| 850649-61-5

Structure of Alogliptin
CAS No.: 850649-61-5

Chemical Structure| 850649-61-5

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Alogliptin is a dipeptidyl peptidase 4 (DPP-4) inhibitor with IC50 of 6.9 nM that exhibits greater selective than DPP-2, DPP-8 and DPP-9.

Synonyms: SYR-322 free base; SYR 322

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Alogliptin

CAS No. :850649-61-5
Formula : C18H21N5O2
M.W : 339.39
SMILES Code : N#CC1=CC=CC=C1CN(C(N2C)=O)C(N3C[C@H](N)CCC3)=CC2=O
Synonyms :
SYR-322 free base; SYR 322
MDL No. :MFCD09833196
InChI Key :ZSBOMTDTBDDKMP-OAHLLOKOSA-N
Pubchem ID :11450633

Safety of Alogliptin

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Isoform Comparison

Biological Activity

Clinical Trial:

NCT Number Conditions Phases Recruitment Completion Date Locations
NCT03492580 - Completed - United States, New Jersey ... More >> Janssen Investigative Site Titusville, New Jersey, United States, 08560 Less <<
NCT02312427 Heart Failure ... More >> Diabetes Mellitus Less << Phase 4 Completed - Japan ... More >> Mitsui Memorial Hospital Taito-ku, Tokyo, Japan Less <<
NCT02528019 Effects of the DPP-4 Inhibitor... More >>s or SGLT2 Inhibitors on the Protective Actions for Diabetic Complications Less << Phase 4 Unknown August 2018 Japan ... More >> Kurume University Hospital Recruiting Kurume city, Japan, 830-0011 Contact: Nobuhiro Tahara, MD, PhD    +81-942-31-7580    ntahara@med.kurume-u.ac.jp    Contact: Sho-ichi Yamagishi, MD, PhD    +81-942-31-7562       Principal Investigator: Nobuhiro Tahara, MD, PhD Less <<
NCT00751868 Breast Cancer Phase 2 Completed - Italy ... More >> Azienza Osped.Treviglio - Caravaggio Treviglio, BG, Italy, 24047 Azienda Ospedaliera G. Rummo Benevento, BN, Italy, 82100 Ospedale Civile di Campobasso - A. Cardarelli Campabasso, CB, Italy, 86100 Ospedale civile Renzetti di Lanciano Lanciano, CH, Italy, 66034 Azienda Ospedaliera S. Anna Como, CO, Italy, 22100 Azienda Ospedaliera Nesina Garibaldi Catania, CT, Italy, 95124 I.S.T. - Istituto Nazionale per la Ricerca sul Cancro Genova, GE, Italy, 16131 Presidio Ospedaliero di Macerata Mecerata, MC, Italy, 62100 I.R.C.C.S. Multimedica - Casa di Cura Accreditata Sesto San Giovanni, Milano, Italy, 20099 Azienda Ospedaliera R. Silvestrini Perugia, PG, Italy, 06132 Azienda Ospedaliera SS. Annunziata Sassari, SS, Italy, 07100 Ospedale S. Cuore Don Calabria Negrar, Verona, Italy, 37024 Ist. Nazionale per lo Studio e la Cura dei Tumori - Fondazione Pascale Napoli, Italy, 80131 Università Federico II Napoli, Italy, 80131 Istituto Regina Elena Roma, Italy, 00100 Less <<
NCT01075763 - Completed - -
NCT00763347 Diabetes Mellitus Phase 2 Terminated(Voluntarily termina... More >>ted based on preliminary non-clinical findings.) Less << - -
NCT03014479 Type 2 Diabetes Phase 4 Completed - Japan ... More >> Nagoya, Aichi, Japan Kanra, Gunma, Japan Kobe, Hyogo, Japan Koga, Ibaraki, Japan Kawasaki, Kanagawa, Japan Sagamihara, Kanagawa, Japan Yamato, Kanagawa, Japan Sendai, Miyagi, Japan Kashihara, Nara, Japan Kashiwara, Osaka, Japan Suita, Osaka, Japan Okegawa, Saitama, Japan Oyama, Tochigi, Japan Adachi-ku, Tokyo, Japan Chuo-ku, Tokyo, Japan Edogawa-ku, Tokyo, Japan Musashino, Tokyo, Japan Oota-ku, Tokyo, Japan Shibuya-ku, Tokyo, Japan Shinagawa-ku, Tokyo, Japan Shinjuku-ku, Tokyo, Japan Shinjyuku-ku, Tokyo, Japan Osaka, Japan Less <<
NCT01588587 - Unknown December 2017 Japan ... More >> Kurume University Not yet recruiting Kurume, Fukuoka, Japan, 830-0111 Contact: Sho-ichi Yamagishi, MD    +81-942-31-7873    shoichi@med.kurume-u.ac.jp    Sub-Investigator: Sho-ichi Yamagishi, MD          Nagaoka Red Cross Hospital Not yet recruiting Nagaoka, Niigata, Japan, 940-2085 Contact: Kyuzi Kamoi, MD    +81-0258-28-3600    kkam-int@echogo.ne.jp    Principal Investigator: Kyuzi Kamoi, MD          Sub-Investigator: Sho-ichi Yamagishi, MD Less <<
NCT02683226 Polycystic Ovary Syndrome ... More >> Insulin Resistance Less << Phase 4 Completed - Slovenia ... More >> University Medical Center Ljubljana Ljubljana, Slovenia, 1000 Less <<
NCT01632007 Diabetes Mellitus Phase 3 Completed - Japan ... More >> Akita-shi, Akita, Japan Matsudo-shi, Chiba, Japan Fukuoka-shi, Fukuoka, Japan Fukuyama-shi, Hiroshima, Japan Ishikari-shi, Hokkaido, Japan Nakagawa-gun, Hokkaido, Japan Sapporo-shi, Hokkaido, Japan Naka-shi, Ibaragi, Japan Sagamihara-shi, Kanagawa, Japan Kumamoto-shi, Kumamoto, Japan Kashiwara-shi, Osaka, Japan Osaka-shi, Osaka, Japan Suita-shi, Osaka, Japan Arakawa-ku, Tokyo, Japan Bunkyo-ku, Tokyo, Japan Chiyoda-ku, Tokyo, Japan Chuo-ku, Tokyo, Japan Itabashi-ku, Tokyo, Japan Katsushika-ku, Tokyo, Japan Mitaka-shi, Tokyo, Japan Shinjuku-ku, Tokyo, Japan Shunan-shi, Yamaguchi, Japan Less <<
NCT00755846 Diabetes Mellitus Phase 2 Completed - -
NCT01686711 Diabetes Mellitus Phase 4 Completed - Japan ... More >> Hirosaki-shi, Aomori, Japan Kisaratsu-shi, Chiba, Japan Matsuyama-shi, Ehime, Japan Fukuoka-shi, Fukuoka, Japan Kitakyushu-shi, Fukuoka, Japan Kurume-shi, Fukuoka, Japan Fukuyama-shi, Hiroshima, Japan Hiroshima-shi, Hiroshima, Japan Sapporo-shi, Hokkaido, Japan Koga-shi, Ibaraki, Japan Yokohama-shi, Kanagawa, Japan Kumamoto-shi, Kumamoto, Japan Miyazaki-shi, Miyazaki, Japan Suita-shi, Osaka, Japan Koshigaya-shi, Saitama, Japan Otsu-shi, Shiga, Japan Chiyoda-ku, Tokyo, Japan Chuo-ku, Tokyo, Japan Itabashi-ku, Tokyo, Japan Meguro-ku, Tokyo, Japan Minato-ku, Tokyo, Japan Ohta-ku, Tokyo, Japan Shinjuku-ku, Tokyo, Japan Toyama-shi, Toyama, Japan Shimonoseki-shi, Yamaguchi, Japan Less <<
NCT03231709 Type 2 Diabetes Mellitus Phase 4 Completed - Japan ... More >> OCROM Clinic Suita, Osaka, Japan ToCROM Clinic Shinjuku, Tokyo, Japan Less <<
NCT02823808 Diabetes Phase 4 Recruiting December 2021 Korea, Republic of ... More >> Kyunghee University Medical Center Recruiting Seoul, Korea, Republic of Contact: Sang Youl Rhee Less <<
NCT00755846 - Completed - -
NCT02426294 Type 2 Diabetes Mellitus Phase 4 Unknown May 2016 Korea, Republic of ... More >> Pusan National University Hospital Recruiting Busan, Korea, Republic of, 602-739 Contact: Sang Soo Kim, MD., PhD.    +82-51-240-7228    drsskim7@gmail.com    Contact: Jong Ho Kim, MD.    +82-51-240-7983    bedaya@hanmail.net Less <<
NCT02276274 Clinical Pharmacology Phase 3 Completed - Japan ... More >> Fukuoka-shi, Fukuoka, Japan Less <<
NCT01263470 - Completed - -
NCT01075763 Alzheimer's Disease Phase 2 Completed - Italy ... More >> U.VA. Neurologia - Azienda Ospedaliera Garibaldi Nesina Catania, CT, Italy, 95122 Less <<
NCT01263470 Diabetes Mellitus, Type 2 Phase 2 Completed - Japan ... More >> Okayama, Japan, 701-0192 Less <<
NCT01263496 Type 2 Diabetes Mellitus Phase 2 Completed - -
NCT00432276 Diabetes Mellitus Phase 3 Completed - -
NCT02276274 - Completed - -
NCT02763007 Diabetes Mellitus, Type 2 Phase 4 Recruiting September 2020 Korea, Republic of ... More >> Seoul St Mary's Hospital, The Catholic University of Korea Recruiting Seoul, Korea, Republic of, 137-701 Contact: YOON HEE CHOI, MD          Principal Investigator: Kun-Ho Yoon, MD, PhD          Sub-Investigator: Yoon-Hee Choi, MD, PhD          Sub-Investigator: Eun-Young Lee, MD, PhD Less <<
NCT00432276 - Completed - -
NCT00328627 Type 2 Diabetes Mellitus Phase 3 Completed - -
NCT00395512 Diabetes Mellitus Phase 3 Completed - -
NCT00286494 - Completed - -
NCT01263496 - Completed - -
NCT01964976 - Completed - -
NCT00286494 Diabetes Mellitus Phase 3 Completed - -
NCT00286442 Diabetes Mellitus Phase 3 Completed - -
NCT02798172 Diabetes Mellitus, Type 2 Not Applicable Completed - -
NCT01964976 - Completed - Japan ... More >> Tokyo, Japan Less <<
NCT01964950 - Completed - Japan ... More >> Tokyo, Japan Less <<
NCT00328627 - Completed - -
NCT00395512 - Completed - -
NCT00286442 - Completed - -
NCT01964950 - Completed - -
NCT01664624 Type 2 Diabetes Phase 1 Completed - United States, California ... More >> Chula Vista, California, United States United States, Florida Orlando, Florida, United States Less <<
NCT01664624 - Completed - -
NCT02231021 Type 2 Diabetes Mellitus Phase 4 Recruiting November 2018 Korea, Republic of ... More >> Seoul St Mary's Hospital, The Catholic University of Korea Recruiting Seoul, Korea, Republic of, 137-701 Principal Investigator: Kun-Ho Yoon, MD, PhD          Sub-Investigator: Yoon-Hee Choi, MD, PhD          Sub-Investigator: Hye-Kyung Yang, MD Less <<
NCT01263483 Type 2 Diabetes Mellitus Phase 2 Phase 3 Completed - -
NCT01263483 - Completed - -
NCT01318135 - Completed - -
NCT00655863 Diabetes Mellitus Phase 3 Completed - Netherlands ... More >> Amsterdam, Netherlands Sweden Gothenburg, Sweden Less <<
NCT01318135 Type 2 Diabetes Mellitus Phase 2 Phase 3 Completed - -
NCT00286429 Diabetes Mellitus Phase 3 Completed - -
NCT01289119 Diabetes Mellitus, Type 2 Phase 3 Completed - -
NCT01289119 - Completed - -
NCT00286468 Diabetes Mellitus Phase 3 Completed - -
NCT01318109 - Completed - -
NCT00286468 - Completed - -
NCT01023581 Diabetes Mellitus, Type 2 Phase 3 Completed - -
NCT01318109 Type 2 Diabetes Mellitus Phase 2 Phase 3 Completed - -
NCT00286429 - Completed - -
NCT00286455 - Completed - -
NCT01023581 - Completed - -
NCT01318083 - Completed - -
NCT00286455 Diabetes Mellitus Phase 3 Completed - -
NCT01318083 Type 2 Diabetes Mellitus Phase 2 Phase 3 Completed - -
NCT00655863 - Completed - -
NCT01318070 Type 2 Diabetes Mellitus Phase 2 Phase 3 Completed - -
NCT01890122 Diabetes Mellitus Phase 3 Completed - -
NCT01318070 - Completed - -
NCT01890122 - Completed - -
NCT01303055 Diabetes Mellitus, Type 2 Not Applicable Unknown December 2014 Japan ... More >> Dept. of Intern. Med., School of Dentistry, Aichi Gakuin University Recruiting Nagoya, Aichi, Japan, 464-8650 Contact: Takahiro Tosaki, MD, PhD    +81-52-759-2111    nrd49075@nifty.com    Principal Investigator: Takahiro Tosaki, MD, PhD          Sub-Investigator: Keiko Naruse, MD, PhD          Tosaki Clinic for Diabetes and Endocrinology Not yet recruiting Nagoya, Aichi, Japan, 468-0009 Contact: Takahiro Tosaki, MD, PhD       nrd49075@nifty.com    Principal Investigator: Takahiro Tosaki, MD, PhD          Diabetes Clinic, Okazaki East Hospital Recruiting Okazaki, Aichi, Japan, 444-0008 Contact: Takahiro Tosaki, MD, PhD    +81-564-22-6616    nrd49075@nifty.com    Sub-Investigator: Chizuko Suzuki, MD, PhD          Sub-Investigator: Maiko Mizutani, MD, PhD          Principal Investigator: Takahiro Tosaki, MD, PhD          Diabetes Center, Yokkaichi Social Insurance Hospital Recruiting Yokkaichi, Mie, Japan, 510-0016 Contact: Takahiro Tosaki, MD, PhD    +81-59-331-2000    nrd49075@nifty.com    Sub-Investigator: Miho Miyoshi, MD          Sub-Investigator: Tomoki Majima, MD          Principal Investigator: Takahiro Tosaki, MD, PhD Less <<
NCT02068443 Type 2 Diabetes Mellitus Phase 3 Completed - Japan ... More >> Nagoya-shi, Aichi, Japan Chiba-shi, Chiba, Japan Fukuoka-shi, Fukuoka, Japan Kitakyushu-shi, Fukuoka, Japan Kurume-shi, Fukuoka, Japan Aki-gun, Hiroshima, Japan Hiroshima-shi, Hiroshima, Japan Koga-shi, Ibaraki, Japan Mito-shi, Ibaraki, Japan Tushiura-shi, Ibaraki, Japan Ushiku-shi, Ibaraki, Japan Kanazawa-shi, Ishikawa, Japan Takamatsu-chi, Kagawa, Japan Sendai-shi, Miyagi, Japan Ohita-shi, Ohita, Japan Okinawa-shi, Okinawa, Japan Shimajiri-gun, Okinawa, Japan Kashiwara-shi, Osaka, Japan Osaka-shi, Osaka, Japan Hiki-gun, Saitama, Japan Oyama-shi, Tochigi, Japan Shimotsuke-shi, Tochigi, Japan Koutoh-ku, Tokyo, Japan Meguro-ku, Tokyo, Japan Sagae-shi, Yamagata, Japan Yamagata-shi, Yamagata, Japan Yamaguchi-shi, Yamaguchi, Japan Less <<
NCT00856284 - Completed - -
NCT01263509 Type 2 Diabetes Mellitus Phase 2 Phase 3 Completed - -
NCT00707993 - Completed - -
NCT01521962 Diabetes Mellitus Phase 3 Completed - Japan ... More >> Aomori-shi, Aomori, Japan Hirosaki-shi, Aomori, Japan Kashiwa-shi, Chiba, Japan Kisarazu-shi, Chiba, Japan Kitakyushu-shi, Fukuoka, Japan Aki-gun, Hiroshima, Japan Fukuyama-shi, Hiroshima, Japan Nishinomiya-shi, Hyogo, Japan Koga-shi, Ibaraki, Japan Ushiku-shi, Ibaraki, Japan Kahoku-gun, Ishikawa, Japan Hanamaki-shi, Iwate, Japan Morioka-shi, Iwate, Japan Kagoshima-shi, Kagoshima, Japan Satsuma-sendai-shi, Kagoshima, Japan Kumamoto-shi, Kumamoto, Japan Minamata-shi, Kumamoto, Japan Miyazaki-shi, Miyazaki, Japan Nigata-shi, Nigata, Japan Hirakata-shi, Osaka, Japan Osaka-sayama-shi, Osaka, Japan Osaka-shi, Osaka, Japan Takatsuki-shi, Osaka, Japan Yao-shi, Osaka, Japan Kuki-shi, Saitama, Japan Otsu-shi, Shiga, Japan Hamamatsu-shi, Shizuoka, Japan Shizuoka-shi, Shizuoka, Japan Shimotsuke-shi, Tochigi, Japan Shinagawa-ku, Tokyo, Japan Toyama-shi, Toyama, Japan Sagae-shi, Yamagata, Japan Yamagata-shi, Yamagata, Japan Less <<
NCT01318122 Type 2 Diabetes Mellitus Phase 2 Phase 3 Completed - -
NCT01263509 - Completed - -
NCT02068443 - Completed - -
NCT02508168 Healthy Volunteers Phase 1 Completed - -
NCT00707993 Diabetes Mellitus Phase 3 Completed - -
NCT00306384 Diabetes Mellitus PHASE3 COMPLETED 2025-11-11 Birmingham, Alabama, United St... More >>ates|Peoria, Arizona, United States|Phoenix, Arizona, United States|Anaheim, California, United States|Artesia, California, United States|Fresno, California, United States|Los Angeles, California, United States|Mission Viejo, California, United States|Northridge, California, United States|Orange, California, United States|San Diego, California, United States|Tustin, California, United States|Walnut Creek, California, United States|Colorado Springs, Colorado, United States|Denver, Colorado, United States|Norwalk, Connecticut, United States|Washington, District of Columbia, United States|Clearwater, Florida, United States|Hollywood, Florida, United States|Kissimmee, Florida, United States|Longwood, Florida, United States|New Port Richie, Florida, United States|Ocala, Florida, United States|Ocoee, Florida, United States|St. Cloud, Florida, United States|Lawrenceville, Georgia, United States|Honolulu, Hawaii, United States|Idaho Falls, Idaho, United States|Chicago, Illinois, United States|Avon, Indiana, United States|Elkhart, Indiana, United States|Evansville, Indiana, United States|Lafayette, Indiana, United States|Erlanger, Kentucky, United States|Baltimore, Maryland, United States|Sudbury, Massachusetts, United States|Chesterfield, Missouri, United States|St. Louis, Missouri, United States|Omaha, Nebraska, United States|Berlin, New Jersey, United States|Burlington, North Carolina, United States|Charlotte, North Carolina, United States|Morehead City, North Carolina, United States|Pinehurst, North Carolina, United States|Winston-Salem, North Carolina, United States|Cincinnatti, Ohio, United States|Dayton, Ohio, United States|Tulsa, Oklahoma, United States|Medford, Oregon, United States|Lansdale, Pennsylvania, United States|West Grove, Pennsylvania, United States|Charleston, South Carolina, United States|Columbia, South Carolina, United States|Simpsonville, South Carolina, United States|Bristol, Tennessee, United States|Cookeville, Tennessee, United States|Milan, Tennessee, United States|Dallas, Texas, United States|San Antonio, Texas, United States|Temple, Texas, United States|Texarkana, Texas, United States|Burlington, Vermont, United States|Buenos Aires, La Plata, Argentina|Buenos Aires, Moron, Argentina|Rosario, Sante Fe, Argentina|Buenos Aires, Argentina|Ciudadd Autonoma de Buenos Aires, Argentina|Cordoba, Argentina|Mar del Plata, Argentina|Fortaleza, Ceara, Brazil|Curitiba, Parana, Brazil|Porto Alegre, Rio Grande do Sul, Brazil|Mogi das Cruzes, Sao Paulo, Brazil|Santos, Sao Paulo, Brazil|Sao Paulo, Brazil|Santiago, Chile|Ostrava, Czech Republic|Prague, Czech Republic|Praha, Czech Republic|Sternberk, Czech Republic|Zlin, Czech Republic|Santo Domingo Oeste, Dominican Republic|Aschaffenburg, Germany|Berlin, Germany|Frankfurt, Germany|Hamburg, Germany|Hannover, Germany|Munich, Germany|Nuremberg, Germany|Schwerin, Germany|Wiesbaden, Germany|Witten, Germany|Guatemala, Guatemala|Almere, Netherlands|De Bilt, Netherlands|Geleen, Netherlands|Oud-Beijerland, Netherlands|Rotterdam, Netherlands|Zwijndrecht, Netherlands|Bellavista, Lima, Peru|San Isidro, Lima, Peru|Ica, Peru|Lima, Peru|Bytom, Poland|Kamieniec Zabkowicki, Poland|Krakow, Poland|Leczyca, Poland|Lodz, Poland|Radom, Poland|Pretoria, Gauteng, South Africa|Cape Town, Western Cape, South Africa|Somerset West, Western Cape, South Africa|Durban, South Africa|Johannesburg, South Africa|Parow, South Africa Less <<
NCT00856284 Type 2 Diabetes Mellitus Phase 3 Completed - -
NCT02771093 Type 2 Diabetes Mellitus Phase 4 Completed - Japan ... More >> Naka-city, Ibaragi, Japan Less <<
NCT00306384 Diabetes Mellitus PHASE3 COMPLETED 2025-11-11 Birmingham, Alabama, United St... More >>ates|Peoria, Arizona, United States|Phoenix, Arizona, United States|Anaheim, California, United States|Artesia, California, United States|Fresno, California, United States|Los Angeles, California, United States|Mission Viejo, California, United States|Northridge, California, United States|Orange, California, United States|San Diego, California, United States|Tustin, California, United States|Walnut Creek, California, United States|Colorado Springs, Colorado, United States|Denver, Colorado, United States|Norwalk, Connecticut, United States|Washington, District of Columbia, United States|Clearwater, Florida, United States|Hollywood, Florida, United States|Kissimmee, Florida, United States|Longwood, Florida, United States|New Port Richie, Florida, United States|Ocala, Florida, United States|Ocoee, Florida, United States|St. Cloud, Florida, United States|Lawrenceville, Georgia, United States|Honolulu, Hawaii, United States|Idaho Falls, Idaho, United States|Chicago, Illinois, United States|Avon, Indiana, United States|Elkhart, Indiana, United States|Evansville, Indiana, United States|Lafayette, Indiana, United States|Erlanger, Kentucky, United States|Baltimore, Maryland, United States|Sudbury, Massachusetts, United States|Chesterfield, Missouri, United States|St. Louis, Missouri, United States|Omaha, Nebraska, United States|Berlin, New Jersey, United States|Burlington, North Carolina, United States|Charlotte, North Carolina, United States|Morehead City, North Carolina, United States|Pinehurst, North Carolina, United States|Winston-Salem, North Carolina, United States|Cincinnatti, Ohio, United States|Dayton, Ohio, United States|Tulsa, Oklahoma, United States|Medford, Oregon, United States|Lansdale, Pennsylvania, United States|West Grove, Pennsylvania, United States|Charleston, South Carolina, United States|Columbia, South Carolina, United States|Simpsonville, South Carolina, United States|Bristol, Tennessee, United States|Cookeville, Tennessee, United States|Milan, Tennessee, United States|Dallas, Texas, United States|San Antonio, Texas, United States|Temple, Texas, United States|Texarkana, Texas, United States|Burlington, Vermont, United States|Buenos Aires, La Plata, Argentina|Buenos Aires, Moron, Argentina|Rosario, Sante Fe, Argentina|Buenos Aires, Argentina|Ciudadd Autonoma de Buenos Aires, Argentina|Cordoba, Argentina|Mar del Plata, Argentina|Fortaleza, Ceara, Brazil|Curitiba, Parana, Brazil|Porto Alegre, Rio Grande do Sul, Brazil|Mogi das Cruzes, Sao Paulo, Brazil|Santos, Sao Paulo, Brazil|Sao Paulo, Brazil|Santiago, Chile|Ostrava, Czech Republic|Prague, Czech Republic|Praha, Czech Republic|Sternberk, Czech Republic|Zlin, Czech Republic|Santo Domingo Oeste, Dominican Republic|Aschaffenburg, Germany|Berlin, Germany|Frankfurt, Germany|Hamburg, Germany|Hannover, Germany|Munich, Germany|Nuremberg, Germany|Schwerin, Germany|Wiesbaden, Germany|Witten, Germany|Guatemala, Guatemala|Almere, Netherlands|De Bilt, Netherlands|Geleen, Netherlands|Oud-Beijerland, Netherlands|Rotterdam, Netherlands|Zwijndrecht, Netherlands|Bellavista, Lima, Peru|San Isidro, Lima, Peru|Ica, Peru|Lima, Peru|Bytom, Poland|Kamieniec Zabkowicki, Poland|Krakow, Poland|Leczyca, Poland|Lodz, Poland|Radom, Poland|Pretoria, Gauteng, South Africa|Cape Town, Western Cape, South Africa|Somerset West, Western Cape, South Africa|Durban, South Africa|Johannesburg, South Africa|Parow, South Africa Less <<
NCT01318122 - Completed - -
NCT01391663 - Completed - -
NCT02771093 - Completed - -
NCT01964963 Type 2 Diabetes Mellitus COMPLETED 2017-07-31 Tokyo, Japan
NCT00968708 Diabetes Mellitus, Type 2 ... More >> Acute Coronary Syndrome Less << Phase 3 Completed - -
NCT01945242 Type 2 Diabetes Melitus COMPLETED 2025-06-14 -
NCT01391663 Pharmacokinetics and Pharmacod... More >>ynamics Less << Phase 1 Completed - Korea, Republic of ... More >> Seoul, Korea, Republic of Less <<
NCT01456130 - Completed - -
NCT00957268 Diabetes Mellitus, Type 2 PHASE1 COMPLETED 2025-11-13 Miami, Florida, United States|... More >>Pineallas Park, Florida, United States|Louisville, Kentucky, United States|Durham, North Carolina, United States|Philadelphia, Pennsylvania, United States|Memphis, Tennessee, United States|San Antonio, Texas, United States Less <<
NCT01945242 Type 2 Diabetes Melitus COMPLETED 2025-06-14 -
NCT01456130 Diabetes Mellitus Phase 3 Completed - Japan ... More >> Nagoya-shi, Aichi, Japan Fukuoka-shi, Fukuoka, Japan Kurume-shi, Fukuoka, Japan Sapporo-shi, Hokkaido, Japan Kobe-shi, Hyogo, Japan Kagoshima-shi, Kagoshima, Japan Kumamoto-shi, Kumamoto, Japan Osaki-shi, Miyagi, Japan Minou-shi, Osaka, Japan Osaka-shi, Osaka, Japan Kamio-shi, Saitama, Japan Koshigaya-shi, Saitama, Japan Adachi-ku, Tokyo, Japan Chuo-ku, Tokyo, Japan Less <<
NCT03501277 Healthy Volunteers Phase 1 Completed - Russian Federation ... More >> Non-governmental healthcare Institution Road Clinical Hospital at the station Yaroslavl JSC Russian Railways Yaroslavl, Russian Federation, 150047 Less <<
NCT00968708 - Completed - -
NCT01945216 Type 2 Diabetes Mellitus Who H... More >>ave Been Examined at a Medical Institution Less << COMPLETED 2015-10-31 Osaka, Japan
NCT00957268 Diabetes Mellitus, Type 2 PHASE1 COMPLETED 2025-11-13 Miami, Florida, United States|... More >>Pineallas Park, Florida, United States|Louisville, Kentucky, United States|Durham, North Carolina, United States|Philadelphia, Pennsylvania, United States|Memphis, Tennessee, United States|San Antonio, Texas, United States Less <<
NCT01990300 - Completed - -
NCT02989649 - Terminated(Business Decision; ... More >>No Safety Or Efficacy Concerns) Less << - China, Beijing ... More >> Beijing, Beijing, China China, Hubei Wuhan, Hubei, China China, Liaoning Dalian, Liaoning, China Shenyang, Liaoning, China China, Shandong Jinan, Shandong, China Qingdao, Shandong, China Tai'an, Shandong, China Taian, Shandong, China China, Tianjin Tianjin, Tianjin, China Hong Kong Sai Ying Pun, Hong Kong Sha Tin, Hong Kong Less <<
NCT01945216 Type 2 Diabetes Mellitus Who H... More >>ave Been Examined at a Medical Institution Less << COMPLETED 2015-10-31 Osaka, Japan
NCT03499704 Diabetes Mellitus, Type 2 Phase 4 Not yet recruiting December 31, 2020 -
NCT02756832 - Completed - -
NCT02221284 Type 2 Diabetes Mellitus COMPLETED 2017-06-30 Osaka, Japan|Tokyo, Japan
NCT03042325 Diabetes Mellitus, Type 2 PHASE4 WITHDRAWN 2018-01-15 -
NCT02856113 Diabetes Mellitus, Type 2 Phase 3 Recruiting June 11, 2021 -
NCT03555565 - Active, not recruiting October 31, 2019 Japan ... More >> Takeda Selected Site Tokyo, Japan Less <<

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.95mL

0.59mL

0.29mL

14.73mL

2.95mL

1.47mL

29.46mL

5.89mL

2.95mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2

References

 

Historical Records

Categories